HEMMI – Prize
This research prize is awarded twice a year and we encourage younger researchers in particular to submit their projects.
Research Prize 2024 of the „Hemmi“ Foundation
The “Hemmi Foundation” for the promotion of clinical research
donates in the year 2024
two prizes of 25,000 Swiss francs each.
The call for applications is addressed to young researchers working on a project in the field of medical research in general or in oncology in particular at a Swiss clinic, institute or in private practice. The application should include a description of the project, the study protocol approved by the ethics committee, any results and publications already available, information on the intended purpose and a curriculum vitae.
Candidates are requested to send their application digitally in PDF format, to lic. iur. Simon Rosenthaler, President of the Board of the Hemmi Foundation, rosenthaler@ar-law.ch, by 30 June 2024. We kindly ask you to submit your application in one single PDF file.
The prize winners from 2023
Eliane Rohner MD MSc
Project title:
DNA methylation tests for the detection of persistent precancerous cervical lesions in women living with HIV in Zimbabwe
Institute of Social and Preventive Medicine
University of Bern, 3012 Bern
Cihan Atila Dr. med.
Project title:
Oxytocin Substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial
Department of Endocrinology, Diabetology and Metabolism University Hospital Basel, 4031 Basel
The prize winners from 2022
Christine Schneider MD
Paediatric Oncologist, PhD student
Project title:
Early pulmonary dysfunction in paediatric cancer patients
(SWISS-Pearl Study)
Paediatric Haematology and Oncology, Department of Paediatrics, Inselspital, Bern University Hospital and Department of Paediatric Pulmonology, UKBB Basel
Charly Jehanno MD
Postdoctoral researcher in Molecular biology and Cancerology
Project title:
NNMT evokes epigenetic rewiring and promotes metastatic colonization in breast cancer
University of Basel, Department of Biomedcine Laboratory: Tumor Heterogeneity, Metastasis und Resistance (THMR); Lab Head: Prof. Mohamed Bentires-Alj